The treatment of multiple myeloma using vincristine, carmustine, melphalan, cyclophosphamide, and prednisone (VBMCP) alternating with high-dose cyclophosphamide and alpha(2)beta interferon versus VBMCP: results of a phase III Eastern Cooperative Oncology Group Study E5A93.
Saved in:
| Title: | The treatment of multiple myeloma using vincristine, carmustine, melphalan, cyclophosphamide, and prednisone (VBMCP) alternating with high-dose cyclophosphamide and alpha(2)beta interferon versus VBMCP: results of a phase III Eastern Cooperative Oncology Group Study E5A93. |
|---|---|
| Authors: | Kyle RA (AUTHOR), Jacobus S (AUTHOR), Friedenberg WR (AUTHOR), Slabber CF (AUTHOR), Rajkumar SV (AUTHOR), Greipp PR (AUTHOR), Kyle, Robert A1 (AUTHOR), Jacobus, Susanna (AUTHOR), Friedenberg, William R (AUTHOR), Slabber, Coenraad Frederik (AUTHOR), Rajkumar, S Vincent (AUTHOR), Greipp, Philip R (AUTHOR) |
| Source: | Cancer (0008543X). 5/15/2009, Vol. 115 Issue 10, p2155-2164. 10p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
